Chlorpheniramine maleate (CPM) throat spray may be a safe and effective way of treating COVID-19–induced acute viral pharyngitis (AVP), according to a new case study.
The three patients in the case study presented with AVP and tested positive for COVID-19 (Cureus 15[1]: e34310. doi:10.7759/cureus.34310). All three patients were prescribed CPM 0.5% oral spray, administered by two sprays (0.2 mL each) three to four times once daily, for one week.
The first patient was a 58-year-old